Cognoptix
www.cognoptix.comCognoptix is pioneering a new way to see Alzheimer's disease (AD): a low-cost, practical and non-invasive eye scan that detects beta-amyloid deposits in the lens. Amyloid is the earliest biomarker of AD, and our system can detect it years or decades before amyloid appears in the brain.
Read more
Cognoptix is pioneering a new way to see Alzheimer's disease (AD): a low-cost, practical and non-invasive eye scan that detects beta-amyloid deposits in the lens. Amyloid is the earliest biomarker of AD, and our system can detect it years or decades before amyloid appears in the brain.
Read more
Country
State
Massachusetts
City (Headquarters)
Marlborough
Industry
Employees
11-50
Founded
2019
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Medical Officer
Email ****** @****.comPhone (***) ****-****Scientific Advisor
Email ****** @****.comPhone (***) ****-****Operations Consultant
Email ****** @****.comPhone (***) ****-****
Technologies
(14)
Reach decision makers at Cognoptix
Free credits every month!
Cognoptix FAQ
Marlborough, United States
Medical Equipment Manufacturing
We'll help you understand if Lusha can solve your business needs.
